TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer
Here we summarize 10 years of effort in the development of a biomedical innovation with global projections. This innovation consists of a novel method for the production of therapeutic dendritic-like cells called Tumor Antigen Presenting Cells (TAPCells®). TAPCells-based immunotherapy was tested in...
Guardado en:
Autores principales: | Salazar-Onfray,Flavio, Pereda,Cristián, Reyes,Diego, López,Mercedes N |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2013
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602013000400014 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Avances en inmunoterapia celular contra el melanoma maligno
por: López,Mercedes, et al.
Publicado: (2004) -
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
por: Elena V. Abakushina, et al.
Publicado: (2021) -
SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
por: Yu. A. Khochenkova, et al.
Publicado: (2014) -
Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma
por: Zhang Y, et al.
Publicado: (2021) -
Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers
por: Lana E. Kandalaft, et al.
Publicado: (2021)